Shanghai Fosun Pharmaceutical(Group) Co.,Ltd.’s Net Profit Dropped 32.3% in First Half of 2022

Shanghai Fosun Pharmaceutical(Group) Co.,Ltd. (上海复星医药(集团)股份有限公司) (600196.SH) reported a net profit of 1.9 billion yuan in the first half of 2022, down 32.3% year-on-year.

Meanwhile, the company posted 21.3 billion yuan in revenue, up 25.9% year-on-year.

At the end of the reporting period, it had 98.8 billion yuan in total assets and 51.1 billion yuan in total liabilities, with a liability-to-asset ratio of 51.7%.